Jefferies Financial Group Issues Pessimistic Forecast for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its target price reduced by stock analysts at Jefferies Financial Group from $152.00 to $151.00 in a research note issued on Wednesday,MarketScreener reports. The firm presently has a “buy” rating on the stock. Jefferies Financial Group’s target price points to a potential upside of 28.41% from the company’s previous close.

A number of other research analysts also recently weighed in on the company. Evercore ISI reduced their target price on Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a report on Wednesday. Wall Street Zen lowered Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, January 24th. Bank of America decreased their price objective on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Morgan Stanley lowered their price objective on Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Clorox from $120.00 to $114.00 and set a “neutral” rating on the stock in a research report on Friday, January 16th. One equities research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $117.93.

Clorox Stock Performance

NYSE:CLX opened at $117.59 on Wednesday. The company has a market capitalization of $14.22 billion, a price-to-earnings ratio of 19.21, a PEG ratio of 0.57 and a beta of 0.59. The business has a 50 day moving average of $105.58 and a 200 day moving average of $114.01. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.50. Clorox has a 1-year low of $96.66 and a 1-year high of $159.04.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the business posted $1.55 earnings per share. The company’s revenue was down .8% compared to the same quarter last year. On average, sell-side analysts predict that Clorox will post 7.15 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction dated Friday, November 21st. The shares were purchased at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares in the company, valued at $1,353,690. This represents a 44.44% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

Institutional investors have recently added to or reduced their stakes in the business. Savvy Advisors Inc. increased its holdings in Clorox by 1.4% during the second quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock valued at $768,000 after buying an additional 91 shares during the last quarter. Canandaigua National Bank & Trust Co. grew its position in shares of Clorox by 0.8% during the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock valued at $1,380,000 after acquiring an additional 94 shares during the period. State of Michigan Retirement System increased its stake in shares of Clorox by 0.3% in the 2nd quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock worth $4,028,000 after purchasing an additional 100 shares in the last quarter. Field & Main Bank raised its holdings in Clorox by 3.3% in the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares during the period. Finally, Fisher Asset Management LLC raised its holdings in Clorox by 1.7% in the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock worth $746,000 after purchasing an additional 102 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target to $136 (equal-weight), signaling meaningful upside versus the current level and providing buy-side support. Article Title
• Positive Sentiment: Jefferies kept a Buy rating and a high target (~$151), reinforcing a bullish view on longer-term recovery and giving investors a favorable risk/reward case. Article Title
• Neutral Sentiment: Clorox reiterated its 2026 outlook despite mixed Q2 results, which limits downside if management delivers on guidance and execution. Article Title
• Neutral Sentiment: Clorox will present at the CAGNY conference (Feb. 19), offering investors a near-term opportunity for management to outline strategy and provide more color on ERP integration and potential M&A (GOJO). Article Title
• Negative Sentiment: Q2 results were mixed: adjusted EPS missed estimates ($1.39 vs. $1.43), organic sales fell year-over-year, and margin pressure from higher costs and ERP-related expenses was highlighted — primary near-term negative catalyst. Article Title
• Negative Sentiment: Evercore cut its target sharply to $115 and kept an Underperform rating, increasing sell-side pressure and signalling concerns about near-term profitability. Article Title
• Negative Sentiment: Deutsche Bank trimmed its target to $112 (hold), and TD Cowen’s $111 target (hold) also implies downside — several shops are skeptical on margins and the ERP/integration timeline. Article Title Article Title
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 miss even while nudging its target to $112 — a reminder margins and execution (inventory reset, ERP) are the biggest risks near term. Article Title

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.